# Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-tool

> **NCT03928938** · NA · COMPLETED · sponsor: **Oulu University Hospital** · enrollment: 43 (actual)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Electronic patient reported outcomes

## Key facts

- **NCT ID:** NCT03928938
- **Lead sponsor:** Oulu University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03928938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03928938, "Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-tool". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03928938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*